SCHEMBL887423

SCHEMBL887423

CC(=O)C(C(C)=O)C(NC(=O)c1cccc2ccccc12)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 0.53
MMP3 P08254 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
ALDH1A1 P00352 5/20 0.48
LMNA P02545 1/20 0.47
NR4A1 P22736 1/20 0.46
NR4A2 P43354 1/20 0.46
NR4A3 Q92570 1/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
TACR3 P29371 1/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
THRB P10828 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
DEGS1 O15121 1/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12218397 0.80 ALDH1A1 (0.65) PLK1MMP3HDAC8ALDH1A1LMNA
SCHEMBL887421 0.77 LMNA (0.65) ALDH1A1LMNANPC1HPGDSMN1; SMN2
SCHEMBL8737627 0.76 PLK1 (0.66) PLK1MMP3HDAC8ALDH1A1LMNA
SCHEMBL887413 0.75 NPC1 (0.47) ALDH1A1LMNANPC1RAB9AHPGD
SCHEMBL9831137 0.75 PLK1 (0.60) PLK1MMP3HDAC8ALDH1A1LMNA
SCHEMBL2405015 0.75 PLK1 (0.60) PLK1MMP3HDAC8ALDH1A1LMNA
SCHEMBL9260283 0.74 TACR3 (0.60) PLK1MMP3HDAC8ALDH1A1LMNA
SCHEMBL2408316 0.74 HDAC1 (0.65) PLK1MMP3HDAC8ALDH1A1LMNA
SCHEMBL8024738 0.74 LMNA (0.44) PLK1MMP3HDAC8ALDH1A1LMNA
SCHEMBL9831304 0.73 MMP3 (0.51) PLK1MMP3HDAC8ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902207-B2 Process for production of amines TAKASAGO INTERNATIONAL CORPORATION (JP) 2011-03-08 US disclosed
US-20070142639-A1 Process for production of amines TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142639-A1 Process for production of amines SMS, CCNT1, PEAK1 PLK1 678/4885MMP3 4842/4885HDAC8 4859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.